ARISTO logo

Aristo Bio-Tech And Lifescience Limited

ARISTO·NSE·
₹89.30▼ -4.70 (-5.00%)
Market Cap60.79 Cr
PE Ratio8.46
Volume1,600
Day High - Low89.30 - 89.30
52W High-Low135.00 - 74.30

Aristo Bio-Tech And Lifescience Limited (ARISTO): company summary

The company's business has improved, with annual revenue rising 14.4% and net profit growing 79.5% year-over-year.

Aristo Bio-Tech And Lifescience Limited (ARISTO) is a micro-cap Chemicals company valued at ₹61 crore operating in Pesticides & Agrochemicals on the NSE and BSE.

Recent price move
Aristo Bio-Tech And Lifescience Limited last traded at ₹89.3, sharply down 5.00% on the day.
Financial performance
The company's business has improved, with annual revenue rising 14.4% and net profit growing 79.5% year-over-year. The latest quarter showed revenue up 2.9% compared to the same quarter a year earlier, while net profit remained flat at ₹3 crore.
Valuation multiples
The stock trades at 8.5 times earnings, 1.65 times book value. It yields 0.5%.
Things to watch
The stock is 32.4% below its 52-week high, and the company's net profit margin, though up, remains low at 2.0%. The company's revenue growth has slowed in the latest quarter compared to the strong performance in the previous quarter.
Where it stands
Aristo Bio-Tech and Lifescience Ltd has shown strong growth in both revenue and net profit over the past year, with a net profit margin that has improved. The stock is currently trading below its 52-week high, and the latest quarter's revenue growth was modest compared to the prior quarter.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.5/10
Fair
Fair Value
Sign in to see
ROE
16.14%
Strong
P/E
8.46x
Cheap
Debt / Equity
0.80
Moderate
Industry
Chemicals
Pesticides & Agrochemicals
Overall View
Mixed

Price performance

52W₹74.30
₹135.00
DocStoX take

Supported by growth (9.2) and valuation (8.2), but held back by momentum (1.4). Growth looks strong at 9.2, but that is offset by momentum at 1.4. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.5
/10
Fair
Quality
Solid
ROE 16.1%
Valuation
Cheap
P/E 8.5×
Growth
Strong
Revenue +16.9% 5Y CAGR
Risk
Moderate
D/E 0.80
Momentum
Weak
25% of 52-week range

At a glance

Market Cap
₹61 Cr
52W High / Low
₹135 / ₹74
Dividend Yield
0.46%
Promoter Holding
73.42%
EPS (TTM)
₹10.55
Book Value
₹65.39

Key highlights

  • Profit compounding 48% a year
  • Profitable in all of the last 5 years
  • Undemanding at 8× earnings
  • Momentum is weak (1.4/10)
  • Near the bottom of its 52-week range (25%)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Pesticides & Agrochemicals

Aristo Bio-Tech And Lifescience Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.